Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2017 1
2018 1
2019 1
2020 1
2021 5
2022 2
2023 3
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
The emerging role of regulatory cell-based therapy in autoimmune disease.
Ghobadinezhad F, Ebrahimi N, Mozaffari F, Moradi N, Beiranvand S, Pournazari M, Rezaei-Tazangi F, Khorram R, Afshinpour M, Robino RA, Aref AR, Ferreira LMR. Ghobadinezhad F, et al. Front Immunol. 2022 Dec 14;13:1075813. doi: 10.3389/fimmu.2022.1075813. eCollection 2022. Front Immunol. 2022. PMID: 36591309 Free PMC article. Review.
Therefore, targeting or engineering these cells is a promising therapeutic for different autoimmune diseases. Regulatory T cells, regulatory B cells, regulatory dendritic cells, myeloid suppressor cells, and some subsets of innate lymphoid cells are arising as important pl …
Therefore, targeting or engineering these cells is a promising therapeutic for different autoimmune diseases. Regulatory T cells, regulatory …
Pain management using nanotechnology approaches.
Beiranvand S, Sorori MM. Beiranvand S, et al. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):462-468. doi: 10.1080/21691401.2018.1553885. Artif Cells Nanomed Biotechnol. 2019. PMID: 30688094 Review.
Retraction Statement: Novel NAD-independent Avibacterium paragallinarum: Isolation, characterization and molecular identification in Iran.
[No authors listed] [No authors listed] Vet Med Sci. 2023 Sep;9(5):2390. doi: 10.1002/vms3.1257. Epub 2023 Sep 15. Vet Med Sci. 2023. PMID: 37713440 Free PMC article.
Beiranvand, S., Piri-Gharaghie, T., Dehganzad, B., Khedmati, F., Jalali, F., AsadAlizadeh, M., & Momtaz, H. (2022). ...
Beiranvand, S., Piri-Gharaghie, T., Dehganzad, B., Khedmati, F., Jalali, F., AsadAlizadeh, M., & Momtaz, H. (2022). ...
Putative novel B-cell vaccine candidates identified by reverse vaccinology and genomics approaches to control Acinetobacter baumannii serotypes.
Beiranvand S, Doosti A, Mirzaei SA. Beiranvand S, et al. Infect Genet Evol. 2021 Dec;96:105138. doi: 10.1016/j.meegid.2021.105138. Epub 2021 Nov 15. Infect Genet Evol. 2021. PMID: 34793968 Free article.
The cross-membrane localization of the protein was predicted using PRED-TMBB. B cell epitope prediction was made for immunogenicity using the IEDB and BepiPred-2.0 database. ...
The cross-membrane localization of the protein was predicted using PRED-TMBB. B cell epitope prediction was made for immunogenicity u …
Novel UiO-NH(2)-like Zr-Based MOF (Basu-DPU) as an Excellent Catalyst for Preparation of New 6H-Chromeno[4,3-b]quinolin-6-ones.
Beiranvand M, Habibi D, Khodakarami H. Beiranvand M, et al. ACS Omega. 2023 Jul 12;8(29):25924-25937. doi: 10.1021/acsomega.3c01793. eCollection 2023 Jul 25. ACS Omega. 2023. PMID: 37521649 Free PMC article.
Then, catalytic application of the prepared zirconium-based MOF was successfully explored in the synthesis of novel 6H-chromeno[4,3-b]quinolin-6-ones 4(a-l) through a one-pot three-component condensation reaction of 4-hydroxycumarine, 1-naphthylamine, and aromatic aldehyde …
Then, catalytic application of the prepared zirconium-based MOF was successfully explored in the synthesis of novel 6H-chromeno[4,3-b …
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diseases and Injuries Collaborators. GBD 2021 Diseases and Injuries Collaborators. Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17. Lancet. 2024. PMID: 38642570 Free PMC article.
23 results